HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

TRS

TriMas Corporation

Consumer Cyclical — Packaging & Containers

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace and defense, and industrial markets worldwide. The company operates through Packaging and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Aarts Packaging, Intertech, Omega Plastics, and Rapak brands. The Specialty Products segment designs, manufactures, and distributes steel cylinders for use in transportation, storage, and dispensing of packaged and compressed gases under the Norris Cylinder brand. It sells its products through a direct sales force, third-party agents, and distributors. The company was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.

None 2 analysts
$38.57
$-0.03 (-0.06%)
Target: $45.00 (16.7%)

Price History

52-Week Range
Sign in to add TRS to a watchlist or set price alerts.

Fundamentals

Market Cap$1.55B
P/E Ratio (TTM)123.60
Forward P/E19.94
EPS (TTM)$0.35
Dividend Yield0.37%
Profit Margin137.34%
Revenue Growth10.40%
ROE1.74%
Debt/Equity31.33
Recommendation None
Analyst Target$45.00
Analysts2
Next Earnings Jul 30, 2026 BMO
Indexes -

Technical Indicators

RSI (14)63.3
Beta0.61
SMA 20-
SMA 40-
52-Week High$45.43
52-Week Low$28.98
50-Day Avg$40.45
200-Day Avg$37.02
Avg Volume502.1K
Volume3.8K

Performance Analysis

BULLISH

TRS shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 58% of its 52-week range.
+ RSI at 63.3 shows positive momentum.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- P/E of 123.6 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 10.4% year-over-year.
+ Healthy profit margin of 137.3%.
~ Wall Street consensus is "none" from 2 analysts.
+ Average analyst target of $45.00 implies 16.7% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:35 UTC

Back to Screener Export Report